NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
Figure 7Stability of ML266 in D-PBS pH 7.4 buffer at room temperature over 48 hr
- PMCPubMed Central citations
- PubChem BioAssay for Chemical ProbePubChem BioAssay records reporting screening data for the development of the chemical probe(s) described in this book chapter
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.[Expert Rev Proteomics. 2016]Review Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.Jung O, Patnaik S, Marugan J, Sidransky E, Westbroek W. Expert Rev Proteomics. 2016 May; 13(5):471-9. Epub 2016 Apr 21.
- Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.[J Med Chem. 2012]Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.Patnaik S, Zheng W, Choi JH, Motabar O, Southall N, Westbroek W, Lea WA, Velayati A, Goldin E, Sidransky E, et al. J Med Chem. 2012 Jun 28; 55(12):5734-48. Epub 2012 Jun 8.
- Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease.[bioRxiv. 2024]Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease.Williams D, Glasstetter LM, Jong TT, Kapoor A, Zhu S, Zhu Y, Gehrlein A, Vocadlo DJ, Jagasia R, Marugan JJ, et al. bioRxiv. 2024 Mar 27; . Epub 2024 Mar 27.
- New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.[Chembiochem. 2013]New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.Li Z, Li T, Dai S, Xie X, Ma X, Zhao W, Zhang W, Li J, Wang PG. Chembiochem. 2013 Jul 8; 14(10):1239-47. Epub 2013 Jun 14.
- Review Gaucher disease.[Curr Opin Chem Biol. 2007]Review Gaucher disease.Butters TD. Curr Opin Chem Biol. 2007 Aug; 11(4):412-8. Epub 2007 Jul 23.
- Figure 7, Stability of ML266 in D-PBS pH 7.4 buffer at room temperature over 48 ...Figure 7, Stability of ML266 in D-PBS pH 7.4 buffer at room temperature over 48 hr - Probe Reports from the NIH Molecular Libraries Program
Your browsing activity is empty.
Activity recording is turned off.
See more...